The Relative Strength (RS) Rating for MetLife moved up into a new percentile Friday, as it got a lift from 69 to 74.
IBD's unique RS Rating measures technical performance by showing how a stock's price action over the last 52 weeks compares to that of the other stocks in our database.
History shows that the market's biggest winners tend to have an 80 or better RS Rating in the early stages of their moves. See if MetLife can continue to show renewed price strength and hit that benchmark.
When To Sell Stocks To Lock In Profits And Minimize Losses
While the stock is not near an ideal buy point right now, see if it is able to form and break out of a proper consolidation.
While earnings growth decreased in the company's most recent quarterly report from 18% to -1%, revenue grew 16%, up from 7% in the previous report.
The company earns the No. 3 rank among its peers in the Insurance-Life industry group. Primerica is the top-ranked stock within the group.
RELATED:
Which Stocks Are Showing Rising Relative Strength?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
